Fuente: FierceBiotech Ever since 6-year-old Emily Whitehead became the first patient to receive CAR-T cell therapy in 2012, where T cells were removed from her body and reprogrammed to attack her leukemia before being reinfused, drug developers have tried to make the procedure more accessible to a broader range of patients.